Astrelis
Critical Access Hospital · Kane, PA

UPMC KANE

CCN 391318Voluntary non-profit - Private14 bedsLatest FY 2025
Cost-report basis
HCRIS · as filed
Not audited by Astrelis
The read

A hospital in Kane, PA. It ran an operating loss of 6.9% in FY25 on $13.0M of operating revenue. It held 224 days of cash on hand (72nd percentile among Critical Access Hospitals on liquidity). Only a single comparable reporting year is available, so trend context is limited. Including nonoperating items, the all-in result was positive at 4.8%.

Operating margin · FY25
-6.9%
vs Critical Access Hospitals30th pctl of 824 (FY25)
Days cash on hand · FY25
224d
all sources
vs Critical Access Hospitals72nd pctl of 827 (FY25)
Total operating revenue · FY25
$13.0M
vs Critical Access Hospitals13th pctl of 833 (FY25)
Total margin · incl. nonoperating · FY25
+4.8%
vs Critical Access Hospitals42nd pctl of 824 (FY25)
One point of operating margin at UPMC KANE is about $130K per year (1% of FY25 total operating revenue).

Where UPMC KANE sits among Critical Access Hospitals

Operating margin · FY25 pool · n = 824 of 1,404 filed

Each point is one Critical Access Hospital in the national distribution for this provider type, placed by operating margin. Facilities are not matched on size, case mix, or market — that is the matched-peer comparison in the paid benchmark. The Critical Access Hospital median is -0.2%. Descriptive context only, not a ranking.

-20%-10%0%+10%+20%Critical Access Hospital median -0.24974129749702573%UPMC KANE -6.863695836219503%-20%0%+20%Critical Access Hospital median -0.24974129749702573%UPMC KANE -6.863695836219503%
One critical access hospitalUPMC KANECritical Access Hospital median

The money

$ thousands · HCRIS cost-report basis · as filed, QA-gated

Ratios tell you how this hospital is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio renders only when every input is reported in the filing; a year missing its core lines is not shown; a year whose balance sheet does not reconcile is labeled. Not audited by Astrelis.

Operating margin
-6.9% (FY25)
Operating income ÷ total operating revenue
HCRIS WS G-3
Total margin
+4.8% (FY25)
Net income ÷ total revenue incl. nonoperating
HCRIS WS G-3
Days cash on hand
224d (FY25)
Cash, investments & board-designated reserves ÷ daily operating expense (excl. depreciation)
HCRIS WS G / G-3
Current ratio
Not shown, balance sheet did not reconcile as filed
Total current assets ÷ current liabilities
HCRIS WS G
Equity financing ratio
Not shown, balance sheet did not reconcile as filed
Total net assets ÷ total assets
HCRIS WS G
Days in net patient A/R
Not shown, balance sheet did not reconcile as filed
Net patient receivables ÷ (net patient revenue ÷ 365), same fiscal year
HCRIS WS G / G-3
$ in thousands
Line itemFY25
Patient revenue12,897
Other operating revenue96
Total operating revenue12,993
Total operating expenses13,885
Operating income(892)
Operating margin %-6.9%
Grants & contributions20
Investment income528
Other non-operating, net1,018
Net income674
Net income %+4.6%
1 of 3 years available for this statement.
HCRIS Worksheet G-3 / S-3 · $ thousands · FY25–FY25
FY25 net patient A/R is not shown: gross A/R was not reported on the filing, making the derived net figure spurious (AR quality flag).

How it operates

quality & operational context · CMS public reporting

A 14-bed hospital at 19% occupancy 95% of patient revenue is outpatient.

The metrics this hospital type is judged on: care quality, patient experience, and scale. Each is labeled by evidence class and public source; descriptive context only, never a ranking or adequacy claim.

Scale and flow
Occupancy
19.4%
Verified fact2025
HCRIS WS S-3
Average daily census
2.73
Verified fact2025
HCRIS WS S-3
Staffed beds (acute)
14
Verified fact2025
HCRIS WS S-3
Annual discharges
143
Verified fact2025
HCRIS WS S-3
Average length of stay
3.6d
Verified fact2025
HCRIS WS S-3
Outpatient share of patient revenue
94.6%
Verified fact2025
HCRIS WS G-2 L28
How the care measures up
C. difficile infection (SIR)
Results are based on a shorter time period than required.; Results cannot be calculated for this reporting period.
CMS-reported measure07/01/2024 to 06/30/2025
CMS Care Compare
Hospital-wide unplanned readmission
Results are not available for this reporting period.
CMS-reported measure07/01/2023 to 06/30/2024
CMS Care Compare

Pricing

Pilot
Commercial rates vs Medicare
176%
Commercial negotiated rates as a percent of Medicare rates, outpatient basket.
Hospital price files + Medicare rates

Directional indicator from public price files. Facility-specific rate positioning is the Commercial Pricing Study →

Trajectory

Cost-report basis · single reporting year
Operating margin
-6.9%FY25
Days cash on hand
224 daysFY25

The county this hospital serves

Location, PA
Median household income
$61.7K
vs $82.1K US · $59.7K rural median
Poverty rate
13.7%
vs 12.5% US · 14.3% rural median
Uninsured
4.2%
vs 8.6% US · 8.4% rural median
Age 65+
20.5%
vs 16.8% US · 20.6% rural median
Fair or poor health
Not available
self-reported, adults · CDC PLACES
Primary-care shortage
Designated
HRSA HPSA
Economic context: 15.0% of county personal income is Medicare/Medicaid medical benefits; 31.5% arrives as government transfers (BEA, 2022).

What this hospital means to its county

economic contribution · FY25 cost report
Direct annual spending
$13.9M
total operating expense · reported
Total economic output
$31.9M
× 2.30 output multiplier · estimate, upper bound for rural
Method: NCRHW 2016 study of critical access hospitals (IMPLAN Type II), employment × 1.34, earnings × 1.19; output × 2.30 (AHA national, upper bound for rural). Direct figures are reported values from the facility's HCRIS cost report; multiplied figures are estimates.

CAH Performance Benchmark$2,500Founding Edition

Where this facility is underperforming its matched peer cohort and what that gap is worth, measure by measure. Founding Edition: delivered within 30 days of eligibility confirmation, full refund if the published scope cannot be delivered.

Commercial Pricing Study$10,000CAH only, subject to data validation

Your negotiated commercial rates against Medicare and against peers, from hospitals' own published price files. We validate your hospital's rate file before taking payment.

build aa21187 · 2026-07-23